Page last updated: 2024-08-24

irinotecan and Cachexia

irinotecan has been researched along with Cachexia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, TM; Couch, ME; Kays, JK; Kohli, MD; Koniaris, LG; O'Neill, BH; Shahda, S; Stanley, M; Zimmers, TA1
Mai, M; Takahashi, Y; Yasumoto, K1

Other Studies

2 other study(ies) available for irinotecan and Cachexia

ArticleYear
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
    Journal of cachexia, sarcopenia and muscle, 2018, Volume: 9, Issue:4

    Topics: Adipose Tissue; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Body Weights and Measures; Cachexia; Carcinoma, Pancreatic Ductal; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Oxaliplatin; Pancreatic Neoplasms; Phenotype; Prognosis; Retrospective Studies; Tomography, X-Ray Computed

2018
Chemotherapy under cachectic conditions and the possibility of cachexia-controlled chemotherapy.
    Oncology reports, 2005, Volume: 14, Issue:1

    Topics: Animals; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Camptothecin; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Interleukin-6; Irinotecan; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Survival Analysis; Time Factors; Treatment Outcome

2005